Clinical Trials

Breast Neoplasms

NCT02484677 2023-05-26

5-FU

12 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02549677 2022-10-27

ELEGANT

294 enrolled

Breast Neoplasms

NCT02419742 2022-10-12

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

110 enrolled 10 charts

Breast Neoplasms

NCT04031885 2021-08-24

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Phase 4 Terminated

4 enrolled 9 charts

Breast Neoplasms

NCT04136782 2021-07-20

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Phase 4 Recruiting

110 enrolled

Breast Neoplasms

NCT04766827 2021-02-23

Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor

116 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02445586 2019-10-29

Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer

52 enrolled 41 charts

Breast Neoplasms

NCT03799601 2019-01-10

ALTER-L013

45 enrolled

NSCLC

NCT01094184 2018-03-22

BATMAN

49 enrolled 120 charts

Breast Neoplasms

NCT02088515 2017-03-03

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

290 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT01665417 2017-02-08

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT00774241 2016-11-02

PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer

Phase 4 Withdrawn

Breast Neoplasms

NCT01660542 2016-11-01

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

96 enrolled

Locally Advanced Breast Cancer

NCT02031601 2016-03-29

TCL-1

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02627248 2015-12-10

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

200 enrolled

Breast Neoplasms

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

10 enrolled

Tumor-Agnostic

Neoplasms, Second Primary

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

133 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

44 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00127933 2011-08-10

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

157 enrolled 12 charts

Breast Neoplasms

NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

300 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00280098 2009-12-07

Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT00772681 2009-12-07

Tax-Nazo